Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40QNK | ISIN: US91678A1079 | Ticker-Symbol:
NASDAQ
27.06.25 | 21:59
10,950 US-Dollar
+0,09 % +0,010
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
UPSTREAM BIO INC Chart 1 Jahr
5-Tage-Chart
UPSTREAM BIO INC 5-Tage-Chart

Aktuelle News zur UPSTREAM BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.06.Upstream Bio: Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor3
05.06.Upstream Bio to Present Mechanistic Insights into Verekitug's Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 20251
20.05.Upstream Bio Appoints Stacy Price As CTO1
20.05.Upstream Bio names new chief technology officer1
20.05.Upstream Bio Appoints Stacy Price as Chief Technology Officer92WALTHAM, Mass., May 20, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory...
► Artikel lesen
06.05.Upstream Bio, Inc. reports Q1 results3
06.05.Upstream Bio, Inc. - 10-Q, Quarterly Report1
06.05.Upstream Bio, Inc. - 8-K, Current Report1
UPSTREAM BIO Aktie jetzt für 0€ handeln
01.04.Pre-market Movers: Marblegate Acquisition Corp., iCoreConnect, Hyperscale Data, Upstream Bio, InnovAge Holding413OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.30 A.M. ET).In the Green Marblegate Acquisition Corp. (GATE) is up over 55%...
► Artikel lesen
12.03.Upstream Bio, Inc. - S-8, Securities to be offered to employees in employee benefit plans2
12.03.Upstream Bio, Inc. - 10-K, Annual Report2
12.03.Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights142- Completed enrollment of Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps; top-line data expected in the second half of 2025 - - Completed upsized IPO...
► Artikel lesen
12.03.Upstream Bio, Inc. - 8-K, Current Report1
15.10.24Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares183WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on...
► Artikel lesen
14.10.24HBM Healthcare Investments AG: Erfolgreicher Börsengang des HBM-Portfoliounternehmens Upstream Bio; Kapitalaufnahme von USD 255 Millionen897HBM Healthcare Investments AG / Schlagwort(e): Börsengang Erfolgreicher Börsengang des HBM-Portfoliounternehmens Upstream Bio; Kapitalaufnahme von USD 255 Millionen 14.10.2024...
► Artikel lesen
11.10.24Upstream Bio Prices Upsized IPO Of 15 Mln Shares At $17.00/shr1.026WASHINGTON (dpa-AFX) - Upstream Bio Inc. (UPB) announced the pricing of its upsized initial public offering of 15 million shares of its common stock at a public offering price of $17.00 per...
► Artikel lesen
11.10.24Upstream Bio Announces Pricing of Upsized Initial Public Offering192WALTHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1